References
Fleck E, Dacian S, Dirschinger J, Hall D, Rudolph W (1984) Quantitative changes in stenotic coronary artery lesions during follow-up after PTCA. Circulation 70 (supl II):11–176 (abst)
Holmes DR Jr, Vlietstra RE, Smith HC, et al. (1984) Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 53:Suppl:77C-81C
Kaltenbach M, Kober G, Scherer D, Vallbracht C (1985) Recurrence rate after successful coronary angioplasty. Eur Heart J 6:276–281
Schwartz L, Bourassa MG, Lesperance J, Aldrige HE, et al. (1988) Aspirin and ipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318:1714–1719
Serruys PW, Luijten HE, Beat KJ, Geuskens R, et al. (1988) Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation 77:361–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, T., Tebbe, U., Schrader, J. et al. Pharmacological therapy after coronary angioplasty. Klin Wochenschr 68, 294 (1990). https://doi.org/10.1007/BF02116062
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02116062